1
|
Xu K, Huang P, Wu Y, Liu T, Shao N, Zhao L, Hu X, Chang J, Peng Y, Qu S. Engineered Selenium/Human Serum Albumin Nanoparticles for Efficient Targeted Treatment of Parkinson's Disease via Oral Gavage. ACS NANO 2023; 17:19961-19980. [PMID: 37807265 PMCID: PMC10604087 DOI: 10.1021/acsnano.3c05011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/04/2023] [Accepted: 10/04/2023] [Indexed: 10/10/2023]
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the degeneration of dopamine (DA) neurons in the midbrain substantia nigra pars compacta (SNpc). While existing therapeutic strategies can alleviate PD symptoms, they cannot inhibit DA neuron loss. Herein, a tailor-made human serum albumin (HSA)-based selenium nanosystem (HSA/Se nanoparticles, HSA/Se NPs) to treat PD that can overcome the intestinal epithelial barrier (IEB) and blood-brain barrier (BBB) is described. HSA, a transporter for drug delivery, has superior biological characteristics that make it an ideal potential drug delivery substance. Findings reveal that HSA/Se NPs have lower toxicity and higher efficacy than other selenium species and the ability to overcome the IEB and BBB to enrich DA neurons, which then protect MN9D cells from MPP+-induced neurotoxicity and ameliorate both behavioral deficits and DA neuronal death in MPTP-model mice. Thus, a therapeutic drug delivery system composed of orally gavaged HSA/Se NPs for the treatment of PD is described.
Collapse
Affiliation(s)
- Kai Xu
- Department
of Neurology, Nanfang Hospital, Southern
Medical University, Guangzhou, Guangdong 510515, China
- Guangdong-Hong
Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired
Intelligence, Guangzhou, Guangdong 510515, China
- Key
Laboratory of Mental Health of the Ministry of Education, Southern Medical University, Guangzhou, Guangdong 510515, China
| | - Peng Huang
- Department
of Neurology, Nanfang Hospital, Southern
Medical University, Guangzhou, Guangdong 510515, China
- Guangdong-Hong
Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired
Intelligence, Guangzhou, Guangdong 510515, China
- Key
Laboratory of Mental Health of the Ministry of Education, Southern Medical University, Guangzhou, Guangdong 510515, China
| | - Yixuan Wu
- Department
of Neurology, Nanfang Hospital, Southern
Medical University, Guangzhou, Guangdong 510515, China
- Guangdong-Hong
Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired
Intelligence, Guangzhou, Guangdong 510515, China
- Key
Laboratory of Mental Health of the Ministry of Education, Southern Medical University, Guangzhou, Guangdong 510515, China
| | - Teng Liu
- Department
of Neonatology and Pediatrics, Xiangya Hospital
of Central South University, Changsha, Hunan 410008, China
| | - Ningyi Shao
- Cancer
Centre, Faculty of Health Sciences, University
of Macau, Taipa, Macau Special Administrative Region 999078, China
| | - Lulu Zhao
- Chongqing
Key Laboratory for Pharmaceutical Metabolism Research, The Key Laboratory
of Biochemistry and Molecular Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing 400016, China
| | - Xiaoyan Hu
- Shenzhen
Key Laboratory of Biomimetic Materials and Cellular Immunomodulation,
Institute of Biomedicine and Biotechnology, Shenzhen Institute of
Advanced Technology, Chinese Academy of
Sciences, Shenzhen, Guangdong 518055, China
- University
of Chinese Academy of Sciences, Beijing 100864, China
| | - Junlei Chang
- Shenzhen
Key Laboratory of Biomimetic Materials and Cellular Immunomodulation,
Institute of Biomedicine and Biotechnology, Shenzhen Institute of
Advanced Technology, Chinese Academy of
Sciences, Shenzhen, Guangdong 518055, China
| | - Yongbo Peng
- Chongqing
Key Laboratory for Pharmaceutical Metabolism Research, The Key Laboratory
of Biochemistry and Molecular Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing 400016, China
| | - Shaogang Qu
- Department
of Neurology, Nanfang Hospital, Southern
Medical University, Guangzhou, Guangdong 510515, China
- Guangdong-Hong
Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired
Intelligence, Guangzhou, Guangdong 510515, China
- Key
Laboratory of Mental Health of the Ministry of Education, Southern Medical University, Guangzhou, Guangdong 510515, China
- Department
of Neurology, Ganzhou People’s Hospital, Ganzhou, Jiangxi 341000, China
| |
Collapse
|
2
|
Ramezannejad R, Pourianfar HR, Rezaeian S. Interactive Effects of Selenium, Zinc, and Iron on the Uptake of Selenium in Mycelia of the Culinary-Medicinal Winter Mushroom Flammulina velutipes (Agaricomycetes). Int J Med Mushrooms 2023; 25:75-87. [PMID: 37831514 DOI: 10.1615/intjmedmushrooms.2023050153] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2023]
Abstract
The present study for the first time addressed whether the simultaneous presence of selenium, zinc and iron may have effects on the selenium uptake in the mycelia of the winter mushroom (also known as enoki), Flammulina velutipes. Response surface methodology was used to optimize concentrations of selenium, zinc and iron in the range of 0 to 120 mg L-1. The findings showed that application of selenium, zinc and iron (singly, in pairs, or triads) significantly enhanced the selenium accumulation in the mycelia. The highest amount of the selenium accumulation was observed when selenium (60 mg L-1) and zinc (120 mg L-1) were applied into submerged culture media, concurrently, leading to an 85-fold and 88-fold increase in the selenium content of the mycelia compared to that of the mycelia treated with selenium only and untreated mycelia, respectively. In addition, accumulation of selenium into the mycelia had no deteriorative effects on the mycelial biomass. The findings presented in this study may have implications for daily nutrition and industrial bioproduction of mushroom mycelia enriched with selenium.
Collapse
Affiliation(s)
- Rezvan Ramezannejad
- Industrial Fungi Biotechnology Research Department, Research Institute for Industrial Biotechnology, Academic Center for Education, Culture and Research (ACECR), Khorasan Razavi Branch, Mashhad, Iran
| | - Hamid R Pourianfar
- Industrial Fungi Biotechnology Research Department, Research Institute for Industrial Biotechnology, Academic Center for Education, Culture and Research (ACECR)-Khorasan Razavi Branch, Mashhad, Iran
| | - Sharareh Rezaeian
- Industrial Fungi Biotechnology Research Department, Research Institute for Industrial Biotechnology, Academic Center for Education, Culture and Research, Khorasan Razavi Branch, Mashhad, Iran
| |
Collapse
|
3
|
Angelova G, Brazkova M, Mihaylova D, Slavov A, Petkova N, Blazheva D, Deseva I, Gotova I, Dimitrov Z, Krastanov A. Bioactivity of Biomass and Crude Exopolysaccharides Obtained by Controlled Submerged Cultivation of Medicinal Mushroom Trametes versicolor. J Fungi (Basel) 2022; 8:738. [PMID: 35887493 PMCID: PMC9319109 DOI: 10.3390/jof8070738] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Revised: 07/13/2022] [Accepted: 07/15/2022] [Indexed: 02/06/2023] Open
Abstract
The aim of this study is to characterize the bioactivity of mycelial biomass and crude exopolysaccharides (EPS) produced by Trametes versicolor NBIMCC 8939 and to reveal its nutraceutical potential. The EPS (1.58 g/L) were isolated from a culture broth. The macrofungal biomass was rich in protein, insoluble dietary fibers and glucans. The amino acid composition of the biomass was analyzed and 18 amino acids were detected. Three mycelial biomass extracts were prepared and the highest total polyphenol content (16.11 ± 0.14 mg GAE/g DW) and the total flavonoid content (5.15 ± 0.03 mg QE/g DW) were found in the water extract. The results indicated that the obtained EPS were heteropolysaccharides with glucose as the main building monosaccharide and minor amounts of mannose, xylose, galactose, fucose and glucuronic acid. Fourier Transform Infrared Spectroscopy (FTIR) confirmed the complex structure of the crude EPS. Five probiotic lactic acid bacteria strains were used for the determination of the prebiotic effect of the crude EPS. The anti-inflammatory potential was tested in vitro using cell line HT-29. The significant decrease of IL-1 and IL-8 and increase of TGF-beta expression revealed anti-inflammatory potential of the crude exopolysaccharides from T. versicolor.
Collapse
Affiliation(s)
- Galena Angelova
- Department of Biotechnology, University of Food Technologies, 26 Maritsa Blvd., 4002 Plovdiv, Bulgaria; (G.A.); (D.M.); (A.K.)
| | - Mariya Brazkova
- Department of Biotechnology, University of Food Technologies, 26 Maritsa Blvd., 4002 Plovdiv, Bulgaria; (G.A.); (D.M.); (A.K.)
| | - Dasha Mihaylova
- Department of Biotechnology, University of Food Technologies, 26 Maritsa Blvd., 4002 Plovdiv, Bulgaria; (G.A.); (D.M.); (A.K.)
| | - Anton Slavov
- Department of Organic and Inorganic Chemistry, University of Food Technologies, 26 Maritsa Blvd., 4002 Plovdiv, Bulgaria; (A.S.); (N.P.)
| | - Nadejda Petkova
- Department of Organic and Inorganic Chemistry, University of Food Technologies, 26 Maritsa Blvd., 4002 Plovdiv, Bulgaria; (A.S.); (N.P.)
| | - Denica Blazheva
- Department of Microbiology, University of Food Technologies, 26 Maritsa Blvd., 4002 Plovdiv, Bulgaria;
| | - Ivelina Deseva
- Department of Analytical Chemistry and Physicochemistry, University of Food Technologies, 26 Maritsa Blvd., 4002 Plovdiv, Bulgaria;
| | - Irina Gotova
- LB-Bulgaricum PLC, R&D Center, 1000 Sofia, Bulgaria; (I.G.); (Z.D.)
| | - Zhechko Dimitrov
- LB-Bulgaricum PLC, R&D Center, 1000 Sofia, Bulgaria; (I.G.); (Z.D.)
| | - Albert Krastanov
- Department of Biotechnology, University of Food Technologies, 26 Maritsa Blvd., 4002 Plovdiv, Bulgaria; (G.A.); (D.M.); (A.K.)
| |
Collapse
|
6
|
Kieliszek M, Bierla K, Jiménez-Lamana J, Kot AM, Alcántara-Durán J, Piwowarek K, Błażejak S, Szpunar J. Metabolic Response of the Yeast Candida utilis During Enrichment in Selenium. Int J Mol Sci 2020; 21:ijms21155287. [PMID: 32722488 PMCID: PMC7432028 DOI: 10.3390/ijms21155287] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Revised: 07/22/2020] [Accepted: 07/23/2020] [Indexed: 02/06/2023] Open
Abstract
Selenium (Se) was found to inhibit the growth of the yeast Candida utilis ATCC 9950. Cells cultured in 30 mg selenite/L supplemented medium could bind 1368 µg Se/g of dry weight in their structures. Increased accumulation of trehalose and glycogen was observed, which indicated cell response to stress conditions. The activity of antioxidative enzymes (glutathione peroxidase, glutathione reductase, thioredoxin reductase, and glutathione S-transferase) was significantly higher than that of the control without Se addition. Most Se was bound to water-insoluble protein fraction; in addition, the yeast produced 20–30 nm Se nanoparticles (SeNPs). Part of Se was metabolized to selenomethionine (10%) and selenocysteine (20%). The HPLC-ESI-Orbitrap MS analysis showed the presence of five Se compounds combined with glutathione in the yeast. The obtained results form the basis for further research on the mechanisms of Se metabolism in yeast cells.
Collapse
Affiliation(s)
- Marek Kieliszek
- Department of Food Biotechnology and Microbiology, Institute of Food Sciences, Warsaw University of Life Sciences—SGGW, Nowoursynowska 159 C, 02-776 Warsaw, Poland; (A.M.K.); (K.P.); (S.B.)
- Correspondence: (M.K.); (J.S.)
| | - Katarzyna Bierla
- Institute of Analytical Sciences, IPREM, UMR 5254, CNRS-UPPA, Hélioparc, 2 Avenue Angot, 64053 Pau, France; (K.B.); (J.J.-L.)
| | - Javier Jiménez-Lamana
- Institute of Analytical Sciences, IPREM, UMR 5254, CNRS-UPPA, Hélioparc, 2 Avenue Angot, 64053 Pau, France; (K.B.); (J.J.-L.)
| | - Anna Maria Kot
- Department of Food Biotechnology and Microbiology, Institute of Food Sciences, Warsaw University of Life Sciences—SGGW, Nowoursynowska 159 C, 02-776 Warsaw, Poland; (A.M.K.); (K.P.); (S.B.)
| | - Jaime Alcántara-Durán
- Analytical Chemistry Research Group, Department of Physical and Analytical Chemistry, University of Jaen, 23071 Jaen, Spain;
| | - Kamil Piwowarek
- Department of Food Biotechnology and Microbiology, Institute of Food Sciences, Warsaw University of Life Sciences—SGGW, Nowoursynowska 159 C, 02-776 Warsaw, Poland; (A.M.K.); (K.P.); (S.B.)
| | - Stanisław Błażejak
- Department of Food Biotechnology and Microbiology, Institute of Food Sciences, Warsaw University of Life Sciences—SGGW, Nowoursynowska 159 C, 02-776 Warsaw, Poland; (A.M.K.); (K.P.); (S.B.)
| | - Joanna Szpunar
- Institute of Analytical Sciences, IPREM, UMR 5254, CNRS-UPPA, Hélioparc, 2 Avenue Angot, 64053 Pau, France; (K.B.); (J.J.-L.)
- Correspondence: (M.K.); (J.S.)
| |
Collapse
|